APO Research
Talk to an analyst

APO RESEARCH · REPORT

DPT Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global DPT Vaccines Market Outlook and Growth Opportunities 2026

21 December 2025193 pages

Choose your research edition.

Industry ResearchDPT Vaccines Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal DPT Vaccines Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal DPT Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DPT Vaccines Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal DPT Vaccines Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global DPT Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for DPT Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for DPT Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DPT Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the DPT Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the DPT Vaccines market include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products and Minhai Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global DPT Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of DPT Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents DPT Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the DPT Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

DPT Vaccines Segment by Company

Sanofi Pasteur

GSK

Mitsubishi Tanabe Pharma

KM Biologics

Wuhan Institute of Biological Products

Walvax Biotechnology

Chengdu Institute of Biological Products

Minhai Biotechnology

DPT Vaccines Segment by Type

DTaP

Tdap

DTwP

DPT Vaccines Segment by Age

12 Months Below

12 Months Above

DPT Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global DPT Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions DPT Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify DPT Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze DPT Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DPT Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DPT Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DPT Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the DPT Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DPT Vaccines industry.

Chapter 3: Detailed analysis of DPT Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of DPT Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of DPT Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. DPT Vaccines Industry Trends Table 2. DPT Vaccines Industry Drivers Table 3. DPT Vaccines Industry Opportunities and Challenges Table 4. DPT Vaccines Industry Restraints Table 5. Global DPT Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global DPT Vaccines Revenue Share by Company (2021-2026) Table 7. Global DPT Vaccines Sales Volume by Company (M Doses) & (2021-2026) Table 8. Global DPT Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global DPT Vaccines Average Price (US$/Dose) of Company (2021-2026) Table 10. Global DPT Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global DPT Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global DPT Vaccines Company, Product Type & Application Table 13. Global DPT Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global DPT Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of DTaP Table 18. Significant Companies of Tdap Table 19. Significant Companies of DTwP Table 20. Global DPT Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (M Doses) Table 21. Global DPT Vaccines Sales Volume by Type (2021-2026) & (M Doses) Table 22. Global DPT Vaccines Sales Volume by Type (2027-2032) & (M Doses) Table 23. Global DPT Vaccines Sales Volume Share by Type (2021-2026) Table 24. Global DPT Vaccines Sales Volume Share by Type (2027-2032) Table 25. Global DPT Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global DPT Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global DPT Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global DPT Vaccines Sales Value Share by Type (2021-2026) Table 29. Global DPT Vaccines Sales Value Share by Type (2027-2032) Table 30. Significant Companies of 12 Months Below Table 31. Significant Companies of 12 Months Above Table 32. Global DPT Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (M Doses) Table 33. Global DPT Vaccines Sales Volume by Application (2021-2026) & (M Doses) Table 34. Global DPT Vaccines Sales Volume by Application (2027-2032) & (M Doses) Table 35. Global DPT Vaccines Sales Volume Share by Application (2021-2026) Table 36. Global DPT Vaccines Sales Volume Share by Application (2027-2032) Table 37. Global DPT Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global DPT Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global DPT Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global DPT Vaccines Sales Value Share by Application (2021-2026) Table 41. Global DPT Vaccines Sales Value Share by Application (2027-2032) Table 42. Global DPT Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 43. Global DPT Vaccines Sales by Region (2021-2026) & (M Doses) Table 44. Global DPT Vaccines Sales Market Share by Region (2021-2026) Table 45. Global DPT Vaccines Sales by Region (2027-2032) & (M Doses) Table 46. Global DPT Vaccines Sales Market Share by Region (2027-2032) Table 47. Global DPT Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global DPT Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global DPT Vaccines Sales Value Share by Region (2021-2026) Table 50. Global DPT Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global DPT Vaccines Sales Value Share by Region (2027-2032) Table 52. Global DPT Vaccines Market Average Price (US$/Dose) by Region (2021-2026) Table 53. Global DPT Vaccines Market Average Price (US$/Dose) by Region (2027-2032) Table 54. Global DPT Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Table 55. Global DPT Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global DPT Vaccines Sales by Country (2021-2026) & (M Doses) Table 57. Global DPT Vaccines Sales Market Share by Country (2021-2026) Table 58. Global DPT Vaccines Sales by Country (2027-2032) & (M Doses) Table 59. Global DPT Vaccines Sales Market Share by Country (2027-2032) Table 60. Global DPT Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global DPT Vaccines Sales Value Market Share by Country (2021-2026) Table 62. Global DPT Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global DPT Vaccines Sales Value Market Share by Country (2027-2032) Table 64. Sanofi Pasteur Company Information Table 65. Sanofi Pasteur Business Overview Table 66. Sanofi Pasteur DPT Vaccines Sales (M Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 67. Sanofi Pasteur DPT Vaccines Product Portfolio Table 68. Sanofi Pasteur Recent Development Table 69. GSK Company Information Table 70. GSK Business Overview Table 71. GSK DPT Vaccines Sales (M Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 72. GSK DPT Vaccines Product Portfolio Table 73. GSK Recent Development Table 74. Mitsubishi Tanabe Pharma Company Information Table 75. Mitsubishi Tanabe Pharma Business Overview Table 76. Mitsubishi Tanabe Pharma DPT Vaccines Sales (M Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 77. Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio Table 78. Mitsubishi Tanabe Pharma Recent Development Table 79. KM Biologics Company Information Table 80. KM Biologics Business Overview Table 81. KM Biologics DPT Vaccines Sales (M Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 82. KM Biologics DPT Vaccines Product Portfolio Table 83. KM Biologics Recent Development Table 84. Wuhan Institute of Biological Products Company Information Table 85. Wuhan Institute of Biological Products Business Overview Table 86. Wuhan Institute of Biological Products DPT Vaccines Sales (M Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 87. Wuhan Institute of Biological Products DPT Vaccines Product Portfolio Table 88. Wuhan Institute of Biological Products Recent Development Table 89. Walvax Biotechnology Company Information Table 90. Walvax Biotechnology Business Overview Table 91. Walvax Biotechnology DPT Vaccines Sales (M Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 92. Walvax Biotechnology DPT Vaccines Product Portfolio Table 93. Walvax Biotechnology Recent Development Table 94. Chengdu Institute of Biological Products Company Information Table 95. Chengdu Institute of Biological Products Business Overview Table 96. Chengdu Institute of Biological Products DPT Vaccines Sales (M Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 97. Chengdu Institute of Biological Products DPT Vaccines Product Portfolio Table 98. Chengdu Institute of Biological Products Recent Development Table 99. Minhai Biotechnology Company Information Table 100. Minhai Biotechnology Business Overview Table 101. Minhai Biotechnology DPT Vaccines Sales (M Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 102. Minhai Biotechnology DPT Vaccines Product Portfolio Table 103. Minhai Biotechnology Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. DPT Vaccines Distributors List Table 107. DPT Vaccines Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. DPT Vaccines Product Image Figure 2. Global DPT Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DPT Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global DPT Vaccines Sales (2021-2032) & (M Doses) Figure 5. Global DPT Vaccines Sales Average Price (US$/Dose) & (2021-2032) Figure 6. Global DPT Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. DTaP Image Figure 10. Tdap Image Figure 11. DTwP Image Figure 12. Global DPT Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 13. Global DPT Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global DPT Vaccines Sales Volume Share by Type (2021-2032) Figure 15. Global DPT Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global DPT Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global DPT Vaccines Sales Value Share by Type (2021-2032) Figure 18. 12 Months Below Image Figure 19. 12 Months Above Image Figure 20. Global DPT Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 21. Global DPT Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global DPT Vaccines Sales Volume Share by Application (2021-2032) Figure 23. Global DPT Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global DPT Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global DPT Vaccines Sales Value Share by Application (2021-2032) Figure 26. Global DPT Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 27. Global DPT Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global DPT Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global DPT Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America DPT Vaccines Sales Value (2021-2032) & (US$ Million) Figure 31. North America DPT Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe DPT Vaccines Sales Value (2021-2032) & (US$ Million) Figure 33. Europe DPT Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific DPT Vaccines Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific DPT Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America DPT Vaccines Sales Value (2021-2032) & (US$ Million) Figure 37. South America DPT Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa DPT Vaccines Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa DPT Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt DPT Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt DPT Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt DPT Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. DPT Vaccines Value Chain Figure 125. Manufacturing Cost Structure Figure 126. DPT Vaccines Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • DTaP
  • Tdap
  • DTwP
Applications
  • 12 Months Below
  • 12 Months Above
Companies covered
  • Sanofi Pasteur
  • GSK
  • Mitsubishi Tanabe Pharma
  • KM Biologics
  • Wuhan Institute of Biological Products
  • Walvax Biotechnology
  • Chengdu Institute of Biological Products
  • Minhai Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global DPT Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global DPT Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global DPT Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 DPT Vaccines Market Dynamics
  1. 2.1 DPT Vaccines Industry Trends
  2. 2.2 DPT Vaccines Industry Drivers
  3. 2.3 DPT Vaccines Industry Opportunities and Challenges
  4. 2.4 DPT Vaccines Industry Restraints
3 DPT Vaccines Market by Company
  1. 3.1 Global DPT Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global DPT Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global DPT Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global DPT Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global DPT Vaccines Company Ranking (2024-2026)
  6. 3.6 Global DPT Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global DPT Vaccines Company Product Type and Application
  8. 3.8 Global DPT Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global DPT Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 DPT Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 DPT Vaccines Market by Type
  1. 4.1 DPT Vaccines Type Introduction
  2. 4.1.1 DTaP
  3. 4.1.2 Tdap
  4. 4.1.3 DTwP
  5. 4.2 Global DPT Vaccines Sales Volume by Type
  6. 4.2.1 Global DPT Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global DPT Vaccines Sales Volume by Type (2021-2032)
  8. 4.2.3 Global DPT Vaccines Sales Volume Share by Type (2021-2032)
  9. 4.3 Global DPT Vaccines Sales Value by Type
  10. 4.3.1 Global DPT Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global DPT Vaccines Sales Value by Type (2021-2032)
  12. 4.3.3 Global DPT Vaccines Sales Value Share by Type (2021-2032)
5 DPT Vaccines Market by Application
  1. 5.1 DPT Vaccines Application Introduction
  2. 5.1.1 12 Months Below
  3. 5.1.2 12 Months Above
  4. 5.2 Global DPT Vaccines Sales Volume by Application
  5. 5.2.1 Global DPT Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global DPT Vaccines Sales Volume by Application (2021-2032)
  7. 5.2.3 Global DPT Vaccines Sales Volume Share by Application (2021-2032)
  8. 5.3 Global DPT Vaccines Sales Value by Application
  9. 5.3.1 Global DPT Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global DPT Vaccines Sales Value by Application (2021-2032)
  11. 5.3.3 Global DPT Vaccines Sales Value Share by Application (2021-2032)
6 DPT Vaccines Regional Sales and Value Analysis
  1. 6.1 Global DPT Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global DPT Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global DPT Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global DPT Vaccines Sales by Region (2027-2032)
  5. 6.3 Global DPT Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global DPT Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global DPT Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global DPT Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global DPT Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America DPT Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America DPT Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe DPT Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe DPT Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific DPT Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific DPT Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America DPT Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America DPT Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa DPT Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa DPT Vaccines Sales Value Share by Country, 2025 VS 2032
7 DPT Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global DPT Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global DPT Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global DPT Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global DPT Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global DPT Vaccines Sales by Country (2027-2032)
  6. 7.4 Global DPT Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global DPT Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global DPT Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA DPT Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada DPT Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico DPT Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany DPT Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France DPT Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. DPT Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy DPT Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain DPT Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia DPT Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands DPT Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries DPT Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China DPT Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan DPT Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea DPT Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India DPT Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia DPT Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia DPT Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil DPT Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina DPT Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile DPT Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia DPT Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru DPT Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia DPT Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel DPT Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE DPT Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey DPT Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran DPT Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran DPT Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt DPT Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt DPT Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt DPT Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi Pasteur
  2. 8.1.1 Sanofi Pasteur Company Information
  3. 8.1.2 Sanofi Pasteur Business Overview
  4. 8.1.3 Sanofi Pasteur DPT Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Pasteur DPT Vaccines Product Portfolio
  6. 8.1.5 Sanofi Pasteur Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK DPT Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GSK DPT Vaccines Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 Mitsubishi Tanabe Pharma
  14. 8.3.1 Mitsubishi Tanabe Pharma Company Information
  15. 8.3.2 Mitsubishi Tanabe Pharma Business Overview
  16. 8.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio
  18. 8.3.5 Mitsubishi Tanabe Pharma Recent Developments
  19. 8.4 KM Biologics
  20. 8.4.1 KM Biologics Company Information
  21. 8.4.2 KM Biologics Business Overview
  22. 8.4.3 KM Biologics DPT Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 KM Biologics DPT Vaccines Product Portfolio
  24. 8.4.5 KM Biologics Recent Developments
  25. 8.5 Wuhan Institute of Biological Products
  26. 8.5.1 Wuhan Institute of Biological Products Company Information
  27. 8.5.2 Wuhan Institute of Biological Products Business Overview
  28. 8.5.3 Wuhan Institute of Biological Products DPT Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Wuhan Institute of Biological Products DPT Vaccines Product Portfolio
  30. 8.5.5 Wuhan Institute of Biological Products Recent Developments
  31. 8.6 Walvax Biotechnology
  32. 8.6.1 Walvax Biotechnology Company Information
  33. 8.6.2 Walvax Biotechnology Business Overview
  34. 8.6.3 Walvax Biotechnology DPT Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Walvax Biotechnology DPT Vaccines Product Portfolio
  36. 8.6.5 Walvax Biotechnology Recent Developments
  37. 8.7 Chengdu Institute of Biological Products
  38. 8.7.1 Chengdu Institute of Biological Products Company Information
  39. 8.7.2 Chengdu Institute of Biological Products Business Overview
  40. 8.7.3 Chengdu Institute of Biological Products DPT Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Chengdu Institute of Biological Products DPT Vaccines Product Portfolio
  42. 8.7.5 Chengdu Institute of Biological Products Recent Developments
  43. 8.8 Minhai Biotechnology
  44. 8.8.1 Minhai Biotechnology Company Information
  45. 8.8.2 Minhai Biotechnology Business Overview
  46. 8.8.3 Minhai Biotechnology DPT Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Minhai Biotechnology DPT Vaccines Product Portfolio
  48. 8.8.5 Minhai Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 DPT Vaccines Value Chain Analysis
  2. 9.1.1 DPT Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 DPT Vaccines Sales Mode & Process
  6. 9.2 DPT Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 DPT Vaccines Distributors
  9. 9.2.3 DPT Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst